New Uracil Analog with Exocyclic Methylidene Group Can Reverse Resistance to Taxol in MCF-7 Cancer Cells.

Saved in:
Bibliographic Details
Title: New Uracil Analog with Exocyclic Methylidene Group Can Reverse Resistance to Taxol in MCF-7 Cancer Cells.
Authors: Długosz-Pokorska A; Department of Biomolecular Chemistry, Faculty of Medicine, Medical University of Lodz, Lodz, Poland., Perlikowska R; Department of Biomolecular Chemistry, Faculty of Medicine, Medical University of Lodz, Lodz, Poland., Janecki T; Institute of Organic Chemistry, Faculty of Chemistry, Lodz University of Technology, Lodz, Poland., Janecka A; Department of Biomolecular Chemistry, Faculty of Medicine, Medical University of Lodz, Lodz, Poland.
Source: Biologics : targets & therapy [Biologics] 2023 May 15; Vol. 17, pp. 69-83. Date of Electronic Publication: 2023 May 15 (Print Publication: 2023).
Publication Type: Journal Article
Journal Info: Publisher: Dove Medical Press (NZ) Country of Publication: New Zealand NLM ID: 101321511 Publication Model: eCollection Cited Medium: Print ISSN: 1177-5475 (Print) Linking ISSN: 11775475 NLM ISO Abbreviation: Biologics Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1177-5475
DOI:10.2147/BTT.S405080